Original Article A microRNA contribution to aberrant Ras activation in gastric cancer
Emily KY Lam, Xian Wang, Vivian Y. Shin, Shengjie Zhang, Helen Morrison, Jie Sun, Enders KO Ng, Jun Yu, Hongchuan Jin
Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Biomedical Research Center, Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China; Leibniz Institute for Age Research, Jena, Germany; Department of Surgery, The University of Hong Kong, Hong Kong, China.
Received January 20, 2011; Accepted February 5, 2011; Epub February 6, 2011; Published February 15, 2011
Abstract: Oncogenic Ras mutations are rare in gastric cancer, indicating that other mechanisms may be responsible for aberrant Ras activation in this type of cancer. Ezrin is critical to Ras activation by remodeling cortical actin cytoskeleton. In this study, we aimed to illustrate the relevance and regulation of ezrin in gastric cancer. Ezrin was upregulated in gastric cancer cells. Ezrin siRNA inhibited Ras activation, cell growth and cell migration. Ezrin overexpression was correlated with a poor outcome of gastric cancer patients (n=150, p<0.01). Cox regression analysis revealed a significant value of ezrin expression in prognosis prediction of gastric cancer (relative risk: 2.37, 95% confidence interval: 1.24–4.56, p<0.01). MiR-204, which was predicted to target ezrin, was downregulated in gastric cancer cells and gastric carcinomas (n=22, p<0.01). MiR-204 inhibited ezrin expression, Ras activation, cell growth and cell migration. Importantly, miR-204 suppressed the expression of luciferase controlled by wild-type but not mutated ezrin 3’-UTR. In conclusion, ezrin is important to Ras activation in gastric cancer. Its upregulation is an independent prognosis prediction factor for gastric cancer. By contributing to ezrin upregulation, miR-204 downregulation represents a novel mechanism for aberrant Ras activation in gastric carcinogenesis. (AJTR1101002).
Address all correspondence to: Dr. Xian Wang Biomedical Research Center, Sir Runrun Shaw Hospital Zhejiang University, Hangzhou, China. Tel: +86 571 86006927; Fax: +86 571 86006145 E-mail: wangx118@yahoo.com
Dr. Hongchuan Jin Biomedical Research Center, Sir Runrun Shaw Hospital Zhejiang University, Hangzhou, China. Tel: +86 571 86006366; Fax: +86 571 86006145 E-mail: jinhc@srrsh.com